Latest / Healthcare Scandal Investigations / The Sofa of Gold: How Italy's Drug Czar Hid Millions While Patients Bled

Transcript

The Sofa of Gold: How Italy's Drug Czar Hid Millions While Patients Bled · Healthcare Scandal Investigations

• 0:03
  Speaker 1: The investigators arrived at the Rome apartment expecting paperwork. What
• 0:08
  Speaker 1: they found took 12 hours to catalog. Gold ink gets
• 0:11
  Speaker 1: pressed beneath sofa cushions. Jewels wrapped in cloth and tucked
• 0:15
  Speaker 1: into ottomans. Paintings stacked behind furniture. Gold rubles minted under
• 0:20
  Speaker 1: Tsar Nicholas II. Krugerrand coins sealed inside a mattress. The
• 0:24
  Speaker 1: man who owned all of it had been gone for weeks,
• 0:27
  Speaker 1: already across the border in Switzerland. While the Italian Ministry
• 0:30
  Speaker 1: of Health still listed him as its most senior pharmaceutical official,
• 0:34
  Speaker 1: his name was Duilio Poggiolini, and for a decade he
• 0:38
  Speaker 1: had decided which drugs Italian patients could receive, and at
• 0:41
  Speaker 1: what price. The hidden treasure was not the most disturbing
• 0:45
  Speaker 1: thing investigators would uncover. What lay beneath the corruption, in
• 0:49
  Speaker 1: hospital wards across Italy, in the blood of thousands of
• 0:52
  Speaker 1: people who had simply needed treatment... would take another quarter
• 0:55
  Speaker 1: century to fully surface. To understand how one man could
• 0:59
  Speaker 1: accumulate that much hidden wealth and that much unchecked authority,
• 1:03
  Speaker 1: it helps to trace how long the scaffolding took to build.
• 1:06
  Speaker 1: Duilio Poggiolini was born on July 25th, 1929. He came
• 1:11
  Speaker 1: of age in post-war Italy, a country rebuilding its institutions
• 1:15
  Speaker 1: alongside its bombed cities, a country that placed enormous faith
• 1:19
  Speaker 1: in credentialed expertise. Medicine was a path to respect. Science
• 1:23
  Speaker 1: was a form of patriotism, and Pabbiolini climbed both. He
• 1:27
  Speaker 1: earned his medical degree in 1954. By 1963, he held
• 1:32
  Speaker 1: a professorship in microbiology. Three years later, a second chair
• 1:36
  Speaker 1: in chemotherapy. By 1972, a third in hygiene, and with
• 1:40
  Speaker 1: it a title that would define the next two decades
• 1:42
  Speaker 1: of his life, Inspector General at the Italian Ministry of
• 1:45
  Speaker 1: Health in Rome. Each credential arrived on schedule. Each appointment
• 1:50
  Speaker 1: opened the next door. There was nothing in the public
• 1:53
  Speaker 1: record that looked like ambition outrunning ability. He was, by
• 1:56
  Speaker 1: every visible measure, exactly what Italy's health system needed, a
• 2:00
  Speaker 1: serious scientist moving steadily into serious institutional responsibility. In 1981,
• 2:07
  Speaker 1: Italy appointed him its representative to the World Health Organization's
• 2:10
  Speaker 1: Essential Drugs Program. The WHO posting placed him at the
• 2:15
  Speaker 1: center of international pharmaceutical policy At the precise moment, the
• 2:19
  Speaker 1: global drug market was expanding fastest. He was also, that
• 2:22
  Speaker 1: same year, listed in the documents of the P2 Masonic Lodge,
• 2:26
  Speaker 1: a covert network whose exposure rattled Italian politics, though no
• 2:30
  Speaker 1: specific connection from that membership was ever the center of
• 2:33
  Speaker 1: a criminal case against him. Then came 1982. Francesco di
• 2:38
  Speaker 1: Lorenzo became Italy's Minister of Health, and Pagliolini was appointed
• 2:41
  Speaker 1: General Manager of the Pharmaceutical Department. The title sounds administrative.
• 2:46
  Speaker 1: The actual power it carried was something else entirely. That
• 2:50
  Speaker 1: department controlled which drugs entered Italy's national formulary. The official
• 2:55
  Speaker 1: list of medications the state would purchase and distribute. It
• 2:58
  Speaker 1: also set the prices the state would pay. Every pharmaceutical
• 3:02
  Speaker 1: company operating in Italy needed a favorable decision from that office.
• 3:06
  Speaker 1: And now Duilio Poggiolini ran it. By 1991, he had
• 3:10
  Speaker 1: accumulated three simultaneous European posts. President of the EEC Pharmaceutical
• 3:16
  Speaker 1: Harmonization Commission, Vice President of the Italian Pharmacopoeia Commission, and
• 3:21
  Speaker 1: President of the EU Committee for Proprietary Medical Products. A
• 3:24
  Speaker 1: single man, sitting at the intersection of national and continental
• 3:28
  Speaker 1: drug approval for a decade. His wife, Maria de Pier Poggiolini,
• 3:32
  Speaker 1: was not a figure in the public eye. She managed
• 3:35
  Speaker 1: their household. She also, according to the Supreme Court record,
• 3:39
  Speaker 1: collected the payments. Companies seeking favorable formulary decisions paid. Poggiolini,
• 3:45
  Speaker 1: the court found, masterminded the procedures. Maria received the money.
• 3:50
  Speaker 1: The Swiss bank account holding more than 15 billion lire
• 3:53
  Speaker 1: at the time of his arrest was registered in her name,
• 3:56
  Speaker 1: not his. The distance between his public credentials and his
• 3:59
  Speaker 1: private arrangements was vast, and for 10 years it held.
• 4:03
  Speaker 1: The payments did not arrive as envelopes of cash. They
• 4:06
  Speaker 1: came as decisions, formulary approvals, favorable pricings. Accelerated reviews. The
• 4:12
  Speaker 1: money followed the paperwork. Invisibly, through a system Paudialini understood
• 4:16
  Speaker 1: better than anyone alive. Here is the first image to
• 4:19
  Speaker 1: hold onto. A sofa in Rome. Not a bank vault.
• 4:23
  Speaker 1: Not a numbered account in a discreet financial district. A
• 4:26
  Speaker 1: sofa with its cushions removed, revealing gold ingots stacked in
• 4:30
  Speaker 1: the cavity beneath. Investigators who entered the apartment on September 1st, 1993,
• 4:34
  Speaker 1: spent 12 hours cataloging what they found. twelve hours. Inside
• 4:40
  Speaker 1: the furniture, sofas, mattresses, ottomans, they pulled out gold ingots,
• 4:46
  Speaker 1: cut gems, paintings, Krugerrand coins from South Africa, and gold
• 4:51
  Speaker 1: rubles struck during the reign of Tsar Nicholas II, 1989
• 4:57
  Speaker 1: to 1917. Coins struck during that reign had been hidden
• 5:00
  Speaker 1: inside Italian upholstery for roughly seventy-six years by 1993. The
• 5:06
  Speaker 1: number that emerged from those 12 hours ran into several
• 5:09
  Speaker 1: billion francs. But Poggiolini was not there. The apartment was
• 5:13
  Speaker 1: empty when investigators arrived. He had already left Italy. He
• 5:17
  Speaker 1: was in Switzerland by then, and the record notes he
• 5:20
  Speaker 1: was not found immediately. It took several weeks. He was
• 5:23
  Speaker 1: arrested several weeks later, on October 10th, 1993, in Lausanne.
• 5:29
  Speaker 1: The press had a name ready. King Midas of Health.
• 5:32
  Speaker 1: Now hold the second image alongside the first. Maria Di
• 5:36
  Speaker 1: Pier Poggiolini had signed the paperwork. The account was hers
• 5:40
  Speaker 1: on paper. The Supreme Court would later conclude that Poggiolini
• 5:44
  Speaker 1: masterminded the procedures. She collected. He directed. The legal distance
• 5:49
  Speaker 1: between them had been engineered as deliberately as the furniture
• 5:52
  Speaker 1: in that Rome apartment. Two hiding systems. One in cushions.
• 5:56
  Speaker 1: One in a name. The scale is worth pausing on.
• 5:59
  Speaker 1: The eventual asset seizure reached 39 billion lira total. 29
• 6:04
  Speaker 1: billion attributed to Pogliolini, 10 billion to Maria. The Swiss
• 6:09
  Speaker 1: account holding more than 15 billion lira was part of
• 6:11
  Speaker 1: the assets attributed to Maria, and the overall 39 billion
• 6:15
  Speaker 1: included other seized property. In the final accounting 29 billion
• 6:19
  Speaker 1: was tied to Duilio and 10 billion to Maria was
• 6:22
  Speaker 1: tied to Duilio and 10 billion to Maria, which incorporated
• 6:26
  Speaker 1: the Swiss holdings among other assets. To generate that kind
• 6:29
  Speaker 1: of accumulation across a decade, the payments had to be constant.
• 6:34
  Speaker 1: They had to come from multiple companies, and they had
• 6:36
  Speaker 1: to come for decisions that mattered enormously to the people paying.
• 6:40
  Speaker 1: Every pharmaceutical company operating in Italy knew the mathematics. A
• 6:44
  Speaker 1: favorable formulary listing meant state purchase contracts. An unfavorable one
• 6:49
  Speaker 1: meant nothing. For ten years, the man who made those
• 6:52
  Speaker 1: decisions accumulated gold rubles and Krugerrand coins inside his furniture
• 6:57
  Speaker 1: while the system around him showed no sign of strain.
• 7:00
  Speaker 1: The Manipulite Investigations Clean hands began pulling at Italy's political
• 7:04
  Speaker 1: corruption in 1993. Tangentopoli, they called it, bribery city. Poggiolini
• 7:11
  Speaker 1: was not the only figure swept into that accounting. His
• 7:14
  Speaker 1: direct superior, Health Minister Francesco de Lorenzo, was charged in
• 7:19
  Speaker 1: the same court of auditor's judgment a decade later, found
• 7:22
  Speaker 1: to have damaged the government's image through the same corrupt network.
• 7:26
  Speaker 1: A corruption was not one man's invention. but Poggiolini sat
• 7:30
  Speaker 1: at its pharmaceutical center for an entire decade without interruption.
• 7:34
  Speaker 1: He had time and authority and a bureaucratic architecture that
• 7:38
  Speaker 1: funneled every drug decision through his hands. There is a
• 7:41
  Speaker 1: detail the press did not lead with in 1993. The
• 7:45
  Speaker 1: newspapers called Poggiolini a hoarder. His defense team would later
• 7:49
  Speaker 1: argue something similar, a compulsive psychological condition. a morbid attachment
• 7:54
  Speaker 1: to accumulation that explained the gold and coins and paintings
• 7:58
  Speaker 1: stuffed into furniture. The judges did not accept that argument,
• 8:01
  Speaker 1: but the image of the eccentric collector, the man who
• 8:04
  Speaker 1: simply could not stop acquiring, had taken hold in the
• 8:07
  Speaker 1: public imagination. That image was almost comforting. It suggested a
• 8:11
  Speaker 1: personal flaw, a private disorder, something contained inside one apartment,
• 8:16
  Speaker 1: and one man's psychology. It made the story smaller than
• 8:20
  Speaker 1: it was. But here is the thing. The formulary was
• 8:23
  Speaker 1: not an abstract ledger. It was a list of drugs
• 8:27
  Speaker 1: that sick people received. When Poggiolini approved a medication, it
• 8:31
  Speaker 1: moved into the national health system. When he set a price,
• 8:34
  Speaker 1: the state paid it, and that drug reached patients who
• 8:37
  Speaker 1: had no other mechanism to access it. The decisions that
• 8:40
  Speaker 1: generated his wealth were the same decisions that shaped what
• 8:43
  Speaker 1: treatments were available to Italian patients for ten years. One
• 8:47
  Speaker 1: product was called Sando Globulin. It was a blood plasma derivative.
• 8:51
  Speaker 1: Used primarily to treat hemophiliacs, hemophilia is a condition in
• 8:55
  Speaker 1: which blood does not clot properly. Patients require regular infusions
• 9:00
  Speaker 1: of clotting factors, typically derived from donated human plasma. In
• 9:04
  Speaker 1: the 1980s, before viral inactivation procedures became standard, blood-derived products
• 9:10
  Speaker 1: carried a risk that was known in medical literature, but
• 9:13
  Speaker 1: not yet systematically addressed in Italian distribution. Sandaglobuli, and other
• 9:18
  Speaker 1: plasma derivatives were distributed in Italy without viral screening or
• 9:23
  Speaker 1: viral inactivation. Hemophiliacs received them. Many were infected, some with HIV,
• 9:29
  Speaker 1: some with hepatitis C. By the time investigators began tracing
• 9:33
  Speaker 1: the contaminated blood strand in Italy, the number of identified victims,
• 9:38
  Speaker 1: people who had contracted HIV or hepatitis C from blood
• 9:41
  Speaker 1: products distributed between 1985 and 2008, Reached 2,605, 66,000 claims
• 9:49
  Speaker 1: were eventually filed with the Ministry of Health. The furniture
• 9:52
  Speaker 1: suddenly looked different. Picture a hemophiliac patient in Italy in 1986.
• 9:56
  Speaker 1: He goes to his treatment center. He receives a plasma.
• 10:00
  Speaker 1: derivative that the National Health System has approved and distributed.
• 10:03
  Speaker 1: He does not know whether the plasma was screened for virus.
• 10:06
  Speaker 1: He cannot know. The system that should have told him
• 10:09
  Speaker 1: the system that evaluated these products and set the conditions
• 10:12
  Speaker 1: of their distribution was the same system Poggiolini ran. One
• 10:16
  Speaker 1: version of what happened is this. Poggiolini's corruption was financial.
• 10:21
  Speaker 1: The kickbacks were about money, about which companies got access
• 10:24
  Speaker 1: to the formulary, and at what price. The contaminated blood
• 10:28
  Speaker 1: was a separate catastrophe, a systemic failure common across many
• 10:32
  Speaker 1: countries in the same era. On this reading, the two
• 10:34
  Speaker 1: things overlapped in time and institution without one causing the other.
• 10:39
  Speaker 1: The manslaughter charges filed in December of 2007 named Poggiolini
• 10:43
  Speaker 1: and 10 co-defendants. The trial took years, 12 years after
• 10:47
  Speaker 1: the charges were filed. On March 25th, 2019, Bob Ullini
• 10:52
  Speaker 1: was acquitted on all of them. But that version requires
• 10:55
  Speaker 1: holding two pictures simultaneously without connecting them. A man who
• 10:58
  Speaker 1: received payments to approve drugs. A system that approved blood
• 11:03
  Speaker 1: products without viral safeguards. 2,605 people infected. The acquittal is
• 11:08
  Speaker 1: the legal record. It does not erase the simultaneity. The
• 11:12
  Speaker 1: second version is harder and more systemic. The contaminated blood
• 11:16
  Speaker 1: crisis was not uniquely Italian. France, the United Kingdom, Japan,
• 11:21
  Speaker 1: the United States, every country that distributed unscreened blood products
• 11:26
  Speaker 1: in the 1980s produced victims. The Italian case had distinctive features.
• 11:31
  Speaker 1: The scale, the late adoption of screening, the specific institutional
• 11:35
  Speaker 1: path those products traveled. But the underlying failure was a
• 11:38
  Speaker 1: global one. rooted in a period before the mechanisms of
• 11:41
  Speaker 1: viral transmission and blood products were fully understood and acted upon.
• 11:46
  Speaker 1: Poggiolini's corruption operated inside that same institutional structure. Whether it
• 11:50
  Speaker 1: shaped the specific decisions about blood product safety, or only
• 11:54
  Speaker 1: the financial terms under which companies accessed the market, is
• 11:57
  Speaker 1: precisely what the trial could not resolve to the criminal
• 12:00
  Speaker 1: standard of proof. Of the 2,605 identified infected people, eight
• 12:06
  Speaker 1: individuals were plaintiffs tied directly to the criminal trial. The
• 12:10
  Speaker 1: last of those eight trial-related victims died in 2011. Poggiolini
• 12:14
  Speaker 1: was still alive then, awaiting the verdict that would not
• 12:17
  Speaker 1: come for another eight years. What the record confirms is this. 66,000
• 12:22
  Speaker 1: people filed claims. Approximately 49,000 people were receiving compensation as
• 12:27
  Speaker 1: of December of 2008. A benefit of 1,080 euros every
• 12:31
  Speaker 1: two months. A sum that translates, over years, to something.
• 12:35
  Speaker 1: But not to health. Not to the years lost. not
• 12:38
  Speaker 1: to the treatments that came too late. The memoir Poggiolini
• 12:42
  Speaker 1: wrote was titled Nothing But the Truth. The drugs in Italy,
• 12:46
  Speaker 1: my struggles, my mistakes. The edition was withdrawn and, in
• 12:50
  Speaker 1: the legal language of Italian publishing, matriculated, a process whose
• 12:54
  Speaker 1: full circumstances remain unresolved in the public record. The book exists.
• 12:59
  Speaker 1: It cannot be purchased. What it says about Santo Globuline,
• 13:03
  Speaker 1: about the formulary decisions, about the payments... Those pages are
• 13:07
  Speaker 1: not publicly accessible. A man who spent ten years controlling
• 13:11
  Speaker 1: what Italy's sick could receive wrote a book called Nothing
• 13:14
  Speaker 1: But the Truth. Then the book disappeared. The verdict came
• 13:17
  Speaker 1: on March 25th, 2019. Duilio Poggiolini walked out of that courtroom,
• 13:23
  Speaker 1: acquitted on every manslaughter count. Eleven defendants had faced those charges.
• 13:29
  Speaker 1: The criminal's standard of proof, certainty beyond reasonable doubt, had
• 13:33
  Speaker 1: not been met for any of them. That outcome did
• 13:35
  Speaker 1: not erase the bribery conviction. The Supreme Court had confirmed
• 13:39
  Speaker 1: it years earlier, 20 of 40 kickback counts proven, four
• 13:43
  Speaker 1: years and four months. The conspiracy charge was explicitly excluded.
• 13:48
  Speaker 1: What the court established was a pattern of payments, not
• 13:51
  Speaker 1: a coordinated criminal network with a single purpose. The distinction
• 13:55
  Speaker 1: mattered legally. Whether it mattered morally is a different question,
• 13:59
  Speaker 1: one the law does not answer. The sentence he served
• 14:02
  Speaker 1: was largely house arrest and social services work. On August 30, 2006,
• 14:07
  Speaker 1: a presidential pardon reduced it further to two years. The
• 14:12
  Speaker 1: man who had cataloged bribes across a decade of formulary
• 14:14
  Speaker 1: decisions did not spend a decade behind bars. Then came
• 14:18
  Speaker 1: the accounting of money. In April of 2012, the Supreme
• 14:22
  Speaker 1: Court confirmed the Court of Auditors' ruling. Poggiolini owed $ 5, 164, 000.
• 14:27
  Speaker 1: 569 euros for corruption spanning 1982 to 1992. Francesco de Lorenzo,
• 14:36
  Speaker 1: the minister under whom Pogliolini had operated, was named in
• 14:39
  Speaker 1: the same judgment. Found to have damaged the government's image,
• 14:43
  Speaker 1: the fine was not symbolic, but it arrived 20 years
• 14:46
  Speaker 1: after the last payment was collected and 30 years after
• 14:49
  Speaker 1: the first. The physical assets had already been seized. Maria
• 14:53
  Speaker 1: de Pir did not live to see any of the
• 14:55
  Speaker 1: final rulings. She had been sentenced to four years for bribery.
• 14:59
  Speaker 1: After her release, she returned to the Rome villa with
• 15:02
  Speaker 1: their son, who was living with a brain disease. She
• 15:05
  Speaker 1: died on October 30th, 2007, before the manslaughter trial began
• 15:09
  Speaker 1: in Ermest, before the Court of Auditors' judgment, before any
• 15:12
  Speaker 1: of the closings that would follow. On November 26th, 2014,
• 15:17
  Speaker 1: a presidential decree revoked all of Poggiolini's honors, not in 1993,
• 15:21
  Speaker 1: when he was arrested, not in 2000, when he was convicted.
• 15:23
  Speaker 1: 14 years after the conviction, 21 years after the arrest,
• 15:31
  Speaker 1: the state moved at its own pace. Pagliolini himself outlasted
• 15:35
  Speaker 1: nearly all of it. He died on November 24th, 2020,
• 15:39
  Speaker 1: at the age of 91. And that death, the death
• 15:42
  Speaker 1: of the man who had controlled Italy's pharmaceutical formulary for
• 15:45
  Speaker 1: a decade, who had been arrested fleeing to Switzerland, who
• 15:48
  Speaker 1: had been acquitted of manslaughter after a trial that lasted
• 15:51
  Speaker 1: more than a decade, that death was not publicly announced.
• 15:55
  Speaker 1: Not until October of 2025, nearly five years after his death,
• 16:00
  Speaker 1: the passing was made public. The public records simply held
• 16:03
  Speaker 1: the silence. There is a specific kind of invisibility that
• 16:07
  Speaker 1: public institutions can produce, not the invisibility of a secret,
• 16:11
  Speaker 1: something actively hidden, guarded, destroyed, but the invisibility of a gap,
• 16:16
  Speaker 1: a missing announcement, a book that cannot be purchased, a
• 16:20
  Speaker 1: death that simply was not reported. Duilio Poggiolini spent 37
• 16:24
  Speaker 1: years accumulating credentials that gave him singular authority over what
• 16:29
  Speaker 1: medicines reached Italy's sick. He spent 10 of those years
• 16:32
  Speaker 1: accepting payments to shape those decisions. He spent the years
• 16:36
  Speaker 1: that followed in legal proceedings that outlasted his wife, outlasted
• 16:40
  Speaker 1: most of the victims, and outlasted the public's attention. And
• 16:43
  Speaker 1: then he died, quietly, without announcement, and nearly five years
• 16:48
  Speaker 1: passed before anyone outside his immediate circle appears to have
• 16:51
  Speaker 1: been told. The memoir exists in the record under a
• 16:54
  Speaker 1: title that carries its own weight. Nothing but the truth.
• 16:57
  Speaker 1: It was withdrawn. Its contents, whatever they address about Sanda
• 17:01
  Speaker 1: Globuline and formulary decisions, and the years of payments are
• 17:05
  Speaker 1: not publicly accessible. The circumstances of its withdrawal remain unresolved.
• 17:10
  Speaker 1: What the record does resolve, clearly, is this. The system
• 17:13
  Speaker 1: that produced Poggiolini's authority was not built to detect what
• 17:16
  Speaker 1: he was doing. The formulary approval process, the pricing mechanisms,
• 17:20
  Speaker 1: the relationships between ministry officials and pharmaceutical companies, all of
• 17:25
  Speaker 1: it created structural conditions where a single figure could operate
• 17:28
  Speaker 1: for a decade without triggering a formal investigation. It took
• 17:32
  Speaker 1: Manipulite a sweeping national anti-corruption effort, not a routine audit
• 17:36
  Speaker 1: to surface the payments. The 2012 Court of Auditors' Judgment
• 17:40
  Speaker 1: called it corruption spanning 1982 to 1992, a decade confirmed
• 17:46
  Speaker 1: by the highest court. Eleven people faced the manslaughter charges.
• 17:50
  Speaker 1: All were acquitted. The question the trial asked, whether corrupt
• 17:55
  Speaker 1: decisions caused specific deaths, remains, in the legal sense, unanswered.
• 18:00
  Speaker 1: The question the record raises, whether a system that allowed
• 18:03
  Speaker 1: this to operate for ten years bore some structural responsibility,
• 18:06
  Speaker 1: was never the subject of a criminal trial. The victims
• 18:09
  Speaker 1: are counted in the record 2,605. Each number in that
• 18:14
  Speaker 1: count was a person who received a blood product that
• 18:16
  Speaker 1: had not been screened for the virus it carried. Their
• 18:18
  Speaker 1: infections were identified between 1985 and 2008. Many had been
• 18:23
  Speaker 1: infected in the mid-1980s, but some were not diagnosed until
• 18:27
  Speaker 1: decades later. Some of them waited decades for the diagnosis.
• 18:31
  Speaker 1: Some of them filed claims. Approximately 49,000 people received compensation.
• 18:37
  Speaker 1: The Ethritmet does not resolve into justice. It resolves into
• 18:41
  Speaker 1: a payment, made to people who had already lost what
• 18:44
  Speaker 1: the payment could not restore. Poggiolini lived to 91. He
• 18:48
  Speaker 1: saw the acquittal. He outlasted the trial. What he believed
• 18:52
  Speaker 1: about the decisions he made, the payments he accepted, the
• 18:55
  Speaker 1: products that moved through the formulary he controlled, that is,
• 18:59
  Speaker 1: in a book that cannot be read. The honors the
• 19:01
  Speaker 1: Italian state had given him over four decades were revoked
• 19:05
  Speaker 1: by presidential decree. In 2014, his name was removed from
• 19:09
  Speaker 1: the record of the distinguished. Nearly five years after his death,
• 19:13
  Speaker 1: his passing was made public. There is something in this
• 19:16
  Speaker 1: case that does not resolve neatly, not because the facts
• 19:19
  Speaker 1: are unclear. They are largely confirmed by conviction, by seizure,
• 19:24
  Speaker 1: by court ruling, by compensation rolls, but because the arc
• 19:28
  Speaker 1: of consequence and the arc of accountability ran at different speeds,
• 19:32
  Speaker 1: in different directions, and landed in different places. The gold
• 19:36
  Speaker 1: ingots were cataloged and seized. The victims were counted and compensated.
• 19:40
  Speaker 1: The manslaughter charges were filed and dismissed. The memoir was
• 19:44
  Speaker 1: written and withdrawn. The man died, and the world was
• 19:47
  Speaker 1: not told. What remains is the gap between what was
• 19:50
  Speaker 1: proven and what was experienced by the thousands of people
• 19:53
  Speaker 1: whose claims filled the Ministry of Health's files. That gap
• 19:57
  Speaker 1: is not a legal finding. It is not something a
• 20:00
  Speaker 1: court can close. It is the space where the history
• 20:02
  Speaker 1: of this case actually lives, documented, confirmed, and still open.
• 20:07
  Speaker 1: This show is made by OboMedia.